2011
DOI: 10.1016/s1561-8811(11)80021-0
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of lower extremity vascular disease—a review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 17 publications
0
0
0
Order By: Relevance
“…Table 2 shows no significant difference in the prevalence of significant IABPD among diabetic patients, with approximately 60% of patients showing an IABPD greater than 5 mmHg. These findings align with those from Khanna NN et al(2023) [7] & Santana BV et al( 2023) [8], who reported a high prevalence of IABPD in diabetic patients, which was not necessarily predictive of vascular complications unless the IABPD exceeded 10 mmHg.…”
Section: Observation and Resultssupporting
confidence: 90%
“…Table 2 shows no significant difference in the prevalence of significant IABPD among diabetic patients, with approximately 60% of patients showing an IABPD greater than 5 mmHg. These findings align with those from Khanna NN et al(2023) [7] & Santana BV et al( 2023) [8], who reported a high prevalence of IABPD in diabetic patients, which was not necessarily predictive of vascular complications unless the IABPD exceeded 10 mmHg.…”
Section: Observation and Resultssupporting
confidence: 90%